Viewing register:

PPB

Marketing Authorisation Holder

FOCURE LIMITED

FOREIGN

7

Total Medicines

7

Active

7

Dosage Forms

1

Country

Kenya (7)

Registration Status

Registered 7

Dosage Forms

SPECIFICATION OF THE API: CELECOXIB BP 200 MG , PARACETAMOL BP 325 MG CHLORZOXAZONE USP 250 MG 1 SALICYLIC ACID USP 3%W/W; UREA USP 10 %W/W; LACTIC ACID USP 3 % W/W 1 PARACETAMOL BP 325MG & CELECOXIB BP 200MG 1 ETORICOXIB 60 MG, PARACETAMOL 500 MG 1 ETORICOXIB 120 MG 1 CHLORZOXAZONE 250 MG AND PARACETAMOL 500 MG 1 40MG 1

Therapeutic Classes

GENERIC/BIOSIMILARS 6

NEW/INNOVATOR 1

Local Agents / Applicants

FOCURE LIMITED 7

Registered Medicines

Showing 7 of 7

Product	Form / Strength	Country	Reg. Number	Status
CETACOX 120 ETORICOXIB	ETORICOXIB 120 MG	Kenya	H2022/CTD8870/19774	Registered
CETACOX PLUS ETORICOXIB, PARACETAMOL	ETORICOXIB 60 MG, PARACETAMOL 500 MG	Kenya	H2022/CTD8869/19775	Registered
MYOCURE CHLORZOXAZONE AND PARACETAMOL	CHLORZOXAZONE 250 MG AND PARACETAMOL 500 MG	Kenya	H2021/CTD7498/1876ER	Registered
PROKYN PLUS ESOMEPRAZOLE	40MG	Kenya	H2022/CTD5370/5715ER	Registered
PYNACT MR CELECOXIB, PARACETAMOL AND CHLORZOXAZONE	SPECIFICATION OF THE API: CELECOXIB BP 200 MG , PARACETAMOL BP 325 MG CHLORZOXAZONE USP 250 MG	Kenya	H2024/CTD10730/22204	Registered
PYNACT PLUS PARACETAMOL BP & CELECOXIB BP	PARACETAMOL BP 325MG & CELECOXIB BP 200MG	Kenya	H2024/CTD10727/23020	Registered
SALICURE SALICYLIC ACID, UREA & LACTIC ACID	SALICYLIC ACID USP 3%W/W; UREA USP 10 %W/W; LACTIC ACID USP 3 % W/W	Kenya	H2022/CTD8871/20214	Registered